These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 32852783)

  • 1. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of dorsal root ganglion in a pre-symptomatic subject with familial amyloid polyneuropathy transthyretin E61K.
    Murakami T; Watanabe H; Yamamoto A; Sunada Y
    J Neurol Sci; 2022 Sep; 440():120329. PubMed ID: 35777313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis.
    Murakami T; Sunada Y
    Adv Exp Med Biol; 2019; 1190():371-378. PubMed ID: 31760657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
    Sousa MM; Saraiva MJ
    Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
    Lashuel HA; Lai Z; Kelly JW
    Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
    Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
    J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transthyretin familial amyloid polyneuropathy].
    Kopishinskaya SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyloid neuropathy].
    Ikegawa S
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1371-3. PubMed ID: 1966018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
    Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
    Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy.
    Frigerio R; Fabrizi GM; Ferrarini M; Cavallaro T; Brighina L; Santoro P; Agostoni E; Cavaletti G; Rizzuto N; Ferrarese C
    Amyloid; 2004 Jun; 11(2):121-4. PubMed ID: 15478468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
    Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ
    J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy.
    Palha JA; Moreira P; Olofsson A; Lundgren E; Saraiva MJ
    J Mol Med (Berl); 2001; 78(12):703-7. PubMed ID: 11434723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
    Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.